Search

everythinglearnresearchcommunity

for

Search:↓

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

The new cream is safe and effective for mild to moderate atopic dermatitis.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

The supplement did not work better than a placebo for hair loss in women over 60.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

The 5 mg dose of oral minoxidil is not more effective than the 2.5 mg dose for treating male hair loss.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The treatment was effective for lupus nephritis with manageable side effects.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Finasteride effectively improves hair growth in men with minimal side effects.

Health Education England is moving forward with phase two of their cosmetic intervention project after a successful summit and plans for future training standards.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Daylight photodynamic therapy is effective and well-tolerated for treating actinic keratoses with minimal side effects.

Finasteride treatment increased blood volume and reduced vessel leakiness in beagle prostates.

Testosterone plus finasteride increases bone density in men with spinal cord injuries.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.